This federal contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Novogene Corp Inc., a minority-owned small business. The $151,346.44 firm fixed price purchase order is to perform quality control on de-identified DNA and RNA samples. This work supports NIH's ongoing research into the genetic basis of mood and anxiety disorders, as it will enable whole genome, whole exome, and RNA sequencing of samples collected from individuals with these...
This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
This is a $25,000 Firm Fixed Price purchase order awarded by the National Institute of Mental Health (NIMH) to Novogene Corporation Inc., a minority-owned small business in Sacramento, California. The contract is not set aside. Novogene is providing advanced genomic sequencing and bioinformatics services to support NIMH's scientific research programs. This includes services such as whole genome, transcriptome, metagenomic, and RNA sequencing. Novogene has previously secured multiple federal...
This is a $16,056 Firm Fixed Price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Novogene Corp Inc., a minority-owned small business, for ATAC sequencing of 24 neuronal cell line samples. The work will be performed in Sacramento, CA and the ultimate completion date is May 20, 2025. Novogene is a provider of next-generation sequencing services to various federal agencies, including the NIH, VA, USDA, NOAA, and USGS. This award does not utilize a...
This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
This firm fixed-price purchase order in the amount of $72,600.00 was awarded by the National Institute of Child Health and Human Development (NICHD) to Novogene Corporation Inc., a minority-owned small business, for whole exome sequencing services. The award is for an ongoing project focused on identifying new genetic causes of adrenal and pituitary tumors and analyzing the effects of such genetic alterations. The effort involves DNA library preparation, sequencing, and customized bioinformatics...
This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $11,766 contract is for sequencing and analysis services to be provided by Novogene Corp Inc., a minority-owned small business. The services include next-generation sequencing of DNA and RNA samples, library preparation, and associated bioinformatics analysis. This contract is not designated as...
This firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The $173,475 contract is for Novogene to provide whole genome sequencing and whole genome bisulfite sequencing services for DNA samples to support aging research. The work will be performed in Chula Vista, CA and has a period of performance from July 30, 2021 to July 29, 2022, with a final completion date of October 25, 2022. This requirement was originally posted as a sources sought notice to identify qualified small business providers, but no set-aside was used for the final award.